Showing results (1-10 of 288) with videos related to
Sort By:
Pageof 29
Hepatology Communications|February 16, 2019
Acute Hepatic Porphyrias: Review and Recent ProgressBruce Wang, Sean Rudnick, Brent Cengia, et al.Molecular Genetics and Metabolism|April 17, 2019
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)Herbert L Bonkovsky, Natalia Dixon, Sean RudnickMolecular Genetics and Metabolism Reports|February 9, 2019
Benefits of prophylactic heme therapy in severe acute intermittent porphyriaPradeep Yarra, Denise Faust, Mary Bennett, et al.Drug Design, Development and Therapy|June 23, 2022
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in TherapyChaudry Nasir Majeed, Christopher D Ma, Ted Xiao, et al.The American Journal of Gastroenterology|June 13, 2023
When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury NetworkA Sidney Barritt, Huiman Barnhart, Jiezhun Gu, et al.AME Case Reports|August 2, 2024
Novel UROD mutation for porphyria cutanea tarda, type 2: a case reportStephen Soufleris, Michelle Moore, John D Phillips, et al.Molecular Genetics and Metabolism|June 3, 2019
Pilot study of mitochondrial bioenergetics in subjects with acute porphyriasNatalia Dixon, Ting Li, Brandon Marion, et al.Gastroenterology|January 15, 2023
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert ReviewBruce Wang, Herbert L Bonkovsky, Joseph K Lim, et al.Hematology. American Society of Hematology. Education Program|November 24, 2005
Neurovisceral porphyrias: what a hematologist needs to knowHerbert L BonkovskyWorld Journal of Gastroenterology|December 6, 2013
Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapyWeihong Hou, Herbert L BonkovskyPageof 29